Skip to main content
Back
Watch Compare

TriSalus Life Sciences, Inc.

Data quality: 100%
Also listed as TLSIW Nasdaq
TLSI
Nasdaq Manufacturing Measuring & Analyzing Instruments
$4.22
▼ $0.01 (-0.24%)
Mkt Cap: 261.01 M
Price
$4.25
Mkt Cap
261.01 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -18.93 M
Capital efficient — spends only 2.03% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)53.41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-73.98%
Net Margin-86.88%
Op. Margin-59.68%

Safety

Debt / Equity
N/A
Current Ratio3.05
Interest Coverage-4.86

Valuation

PE (TTM)
-6.65
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -6.7 -1.5
P/B — 1.6
ROE % — -53.3
Net Margin % -86.9 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

5 analysts
Buy
Current
$4.22
+118.0%
Target
$9.20
$7.00
$10.00
$11.00
Forecast
Forward P/E -16.88
Forward EPS -$0.25
Est. Revenue 80.81 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.25
-$0.25 – -$0.25
 80.81 M 1
FY2026 -$0.45
-$0.45 – -$0.45
 59.96 M 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.13 -$0.05 +61.5%
Q32025 -$0.17 -$0.87 -425.7%
Q22025 -$0.22 -$0.23 -2.8%
Q12025 -$0.20 -$0.27 -34.7%

ETFs Holding This Stock

BRSIX BRSIX
0.37% weight
VVICX VVICX
0.01% weight
IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRCIX IRCIX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 53.41% Revenue Growth (3Y) 56.18%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 45.15 M Net Income (TTM) -39.23 M
ROE N/A ROA -100.87%
Gross Margin 84.57% Operating Margin -59.68%
Net Margin -86.88% Free Cash Flow (TTM) -18.93 M
ROIC -73.98% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.05
Interest Coverage -4.86 Asset Turnover 1.16
Working Capital 22.42 M Tangible Book Value -26.73 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.65 Forward P/E N/A
P/B Ratio N/A P/S Ratio 5.78
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.25%
Market Cap 261.01 M Enterprise Value 271.09 M
Per Share
EPS (Diluted TTM) -1.84 Revenue / Share 0.74
FCF / Share -0.31 OCF / Share -0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2.03% FCF Conversion 48.26%
SBC-Adj. FCF -27.25 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 45.15 M 29.43 M 18.51 M — —
Net Income -39.23 M -30.05 M -59.04 M 5.54 M 4.77 M
EPS (Diluted) -1.84 -1.31 -6.73 — —
Gross Profit 38.19 M 25.33 M 15.91 M — —
Operating Income -26.95 M -36.17 M -54.15 M -2.75 M -3.04 M
EBITDA — — — — —
R&D Expenses 14.97 M 17.69 M 29.51 M — —
SG&A Expenses — — — — —
D&A 626,000.0 744,000.0 702,000.0 — —
Interest Expense 5.54 M 3.09 M 16,000.0 — —
Income Tax 7,000.0 6,000.0 9,000.0 570,854.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 35.33 M 23.97 M 25.73 M 20.19 M 252.01 M
Total Liabilities 69.19 M 49.87 M 51.66 M 13.65 M 23.50 M
Shareholders' Equity -33.86 M -25.89 M -25.94 M -13.27 M -21.48 M
Total Debt 33.05 M 22.08 M — — —
Cash & Equivalents 20.44 M 8.53 M 11.78 M 153,563.0 1.33 M
Current Assets 32.24 M 20.67 M 20.86 M 359,892.0 2.01 M
Current Liabilities 11.50 M 10.23 M 14.69 M 2.50 M —